Amarin (AMRN) announced its intent to effect a ratio change on its American Depositary Shares from one ADS representing one ordinary share, to the new ratio of one ADS representing twenty ordinary shares. The effective date of the Ratio Change is expected to be on or about April 11, 2025. The ordinary shares of Amarin Corporation will not be affected by this adjustment. The ADSs will continue to trade on The Nasdaq Capital Market under the symbol “AMRN”. The objective of the Ratio Change is to increase the per share market price of the Company’s ADSs to comply with Nasdaq’s $1.00 minimum bid price per share requirement and maintain the Company’s listing on The Nasdaq Capital Market. On the Effective Date, holders of uncertificated ADSs in the Direct Registration System and in the Depository Trust Company do not need to take any action, as the exchange of every twenty then-held ADSs for one new ADS will occur automatically. Registered holders of certificated ADSs will be required to surrender their certificated ADSs to the depositary bank for cancellation and will receive one new ADS for every twenty existing ADS surrendered. No fractional new ADSs will be issued in connection with the Ratio Change. Rather, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank, and the net cash proceeds from the sale of the fractional ADS entitlements will be distributed to the applicable ADS holders by the depositary bank. As a result of the Ratio Change, the trading price of the Company’s ADSs is expected to increase proportionally, but the Company can give no assurance that the trading price per ADS after the Ratio Change will be equal to or greater than twenty (20) times the trading price per ADS before the adjustment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRN:
- Amarin reports Q4 adjusted EPS (2c) vs. 0c last year
- Amarin expects cash to support continuing operations for ‘foreseeable future’
- Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
- Amarin Corporation Plc (AMRN) Q4 Earnings Cheat Sheet
- Amarin’s vascepa shows cardiovascular efficacy in published trial
Questions or Comments about the article? Write to editor@tipranks.com